Prescription and over-the-counter medications
Medi-Fare Drug and Home Health Center
CGMP Deviations: Syringes were filled with 19mL of potassium chloride when the labels displayed a fill of 20mL.
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Gaia Ethnobotanical
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Gaia Ethnobotanical
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Failed Stability Specifications: Out-of-specification for viscosity, pH and specific gravity
Labeling: Not Elsewhere Classified - A private label distributor noted unfiled NDC numbers on EQ ClearLax Polyethylene Glycol 3350 NF Powder Solution of various sizes.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Fagron Compounding Services LLC
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Labeling: Incorrect or Missing Lot and/or Exp Date.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Superpotent Drug: High out of specification assay value results for potency.
SCA Pharmaceuticals
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Fagron Compounding Services LLC
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.